Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.
Zhang X, Luo M, Dastagir SR, Nixon M, Khamhoung A, Schmidt A, Lee A, Subbiah N, McLaughlin DC, Moore CL, Gribble M, Bayhi N, Amin V, Pepi R, Pawar S, Lyford TJ, Soman V, Mellen J, Carpenter CL, Turka LA, Wickham TJ, Chen TF.
Zhang X, et al. Among authors: mclaughlin dc.
Nat Commun. 2021 May 11;12(1):2637. doi: 10.1038/s41467-021-22898-3.
Nat Commun. 2021.
PMID: 33976146
Free PMC article.